Suggested use: take one (1) capsule twice daily with or without food. Usage can be safely increased as needed or as recommended by a healthcare provider.
Printed potency
Quantity on the label
No numeric quantity is printed on 12 organism rows of the latest observed label; potency basis Potency is stated through expiry. 12 rows sit inside a proprietary blend, so their individual amounts are not disclosed.
Evidence behind the label
Located human trials per organism
Organism on this label
PubMed records indexed as human randomized controlled trials
Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.
Context
Where this score sits
This formulation scores above 42% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.
Evidence queries are incomplete. A2 uses the known matching records as a lower bound.
Scored using the available matching evidence. Identity: Only the species or an unresolved identity is available. Quantity disclosure: 0.0%. Potency: Potency is stated through expiry.
Axes 3–4
Measurement and brand panel
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
Observed price
undefined: no permitted price observation in this release
Sensitivity
Preference-dependent summary
Preference interval 49.33–66.22; rank uncertainty 1553.00–2837.00; rank class 3.
Versions
Typed label snapshot edges
No typed edge in this release.
Preference tool
Weights slider
The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.
Dr. Ohhira's Probiotics: 5 of 12 observed organisms name a strain, and 1 print a deposit identifier. Latest observed label 295780. Window: NIH DSLD snapshot Sep 2026.
Dr. Ohhira's Probiotics: 1 of 1 observed label snapshots state a potency basis; latest basis is through expiry. Quantities reflect printed organism rows. Window: NIH DSLD snapshot Sep 2026.
Dr. Ohhira's Probiotics: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 63.83 on the 100-point scale; rank class 3 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
Dr. Ohhira's Probiotics has 1 observed versions across 1 formulation groups; last recorded edge type: no typed edge. Window: NIH DSLD snapshot Sep 2026.
Dr. Ohhira's Probiotics: 0 of 1 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.